PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Harrow Health, Inc. (HROW)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS4158581094
CUSIP415858109
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Highlights

Market Cap$879.24M
EPS (TTM)-$0.91
Total Revenue (TTM)$105.21M
Gross Profit (TTM)$73.29M
EBITDA (TTM)-$3.62M
Year Range$7.60 - $25.14
Target Price$29.15
Short %23.05%
Short Ratio12.51

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Harrow Health, Inc.

Popular comparisons: HROW vs. XLV, HROW vs. UNH

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Harrow Health, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5,000.00%10,000.00%15,000.00%20,000.00%25,000.00%FebruaryMarchAprilMayJuneJuly
24,720.00%
279.31%
HROW (Harrow Health, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Harrow Health, Inc. had a return of 121.61% year-to-date (YTD) and 37.74% in the last 12 months. Over the past 10 years, Harrow Health, Inc. had an annualized return of 15.30%, outperforming the S&P 500 benchmark which had an annualized return of 11.13%.


PeriodReturnBenchmark
Year-To-Date121.61%18.81%
1 month38.12%4.34%
6 months154.83%18.91%
1 year37.74%25.30%
5 years (annualized)25.92%13.65%
10 years (annualized)15.30%11.13%

Monthly Returns

The table below presents the monthly returns of HROW, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-14.91%13.64%22.16%-22.98%76.15%16.38%121.61%
20231.76%19.31%18.08%19.23%-25.25%0.95%15.97%-31.30%-5.27%-0.21%-35.63%21.34%-24.12%
2022-13.19%2.80%-11.54%-0.73%6.79%0.69%-7.69%33.78%34.26%-0.33%-7.32%32.38%70.83%
202131.20%-14.78%-11.99%13.63%19.95%0.98%-3.98%18.83%-14.25%11.00%-0.89%-13.60%25.95%
2020-25.19%-5.15%-30.80%17.54%20.49%-3.70%5.18%25.73%-18.87%-14.85%20.80%19.30%-11.83%
20194.75%16.44%-28.24%-6.43%30.26%43.33%-10.92%-30.97%5.05%-11.03%25.00%24.48%36.73%
201810.00%-2.67%-3.30%29.55%-2.19%-1.35%6.82%29.36%-8.55%53.60%10.77%20.30%234.71%
2017-10.40%8.93%70.90%-2.40%-23.34%2.56%-19.38%-29.07%-12.02%-6.83%14.00%-0.58%-32.00%
2016-14.00%-31.54%-2.70%-0.50%-1.27%-3.59%2.93%7.75%-8.63%-29.40%1.12%-8.09%-63.92%
2015-1.73%1.76%6.53%1.00%5.33%-4.35%-3.20%-2.16%-16.62%21.34%-13.61%2.97%-7.60%
2014147.32%4.09%-22.43%5.07%-20.57%23.93%5.91%6.12%-4.87%15.90%-1.74%-11.24%123.21%
2013-15.38%-39.52%18.24%54.75%9.53%-15.20%-13.68%-17.62%-25.37%-8.22%0.48%-19.04%-65.54%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of HROW is 64, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of HROW is 6464
HROW (Harrow Health, Inc.)
The Sharpe Ratio Rank of HROW is 6363Sharpe Ratio Rank
The Sortino Ratio Rank of HROW is 6565Sortino Ratio Rank
The Omega Ratio Rank of HROW is 6969Omega Ratio Rank
The Calmar Ratio Rank of HROW is 6565Calmar Ratio Rank
The Martin Ratio Rank of HROW is 5757Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Harrow Health, Inc. (HROW) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


HROW
Sharpe ratio
The chart of Sharpe ratio for HROW, currently valued at 0.49, compared to the broader market-2.00-1.000.001.002.003.000.49
Sortino ratio
The chart of Sortino ratio for HROW, currently valued at 1.20, compared to the broader market-4.00-2.000.002.004.006.001.20
Omega ratio
The chart of Omega ratio for HROW, currently valued at 1.18, compared to the broader market0.501.001.502.001.18
Calmar ratio
The chart of Calmar ratio for HROW, currently valued at 0.39, compared to the broader market0.002.004.006.000.39
Martin ratio
The chart of Martin ratio for HROW, currently valued at 0.90, compared to the broader market-5.000.005.0010.0015.0020.0025.000.90
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.31, compared to the broader market-2.00-1.000.001.002.003.002.31
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.24, compared to the broader market-4.00-2.000.002.004.006.003.24
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.41, compared to the broader market0.501.001.502.001.41
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.82, compared to the broader market0.002.004.006.001.82
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.57, compared to the broader market-5.000.005.0010.0015.0020.0025.008.57

Sharpe Ratio

The current Harrow Health, Inc. Sharpe ratio is 0.49. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Harrow Health, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00FebruaryMarchAprilMayJuneJuly
0.49
2.31
HROW (Harrow Health, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Harrow Health, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%FebruaryMarchAprilMayJuneJuly
-82.01%
0
HROW (Harrow Health, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Harrow Health, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Harrow Health, Inc. was 99.46%, occurring on Mar 19, 2012. The portfolio has not yet recovered.

The current Harrow Health, Inc. drawdown is 82.01%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.46%Oct 11, 20071118Mar 19, 2012

Volatility

Volatility Chart

The current Harrow Health, Inc. volatility is 14.43%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%FebruaryMarchAprilMayJuneJuly
14.43%
2.04%
HROW (Harrow Health, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Harrow Health, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

P/E Ratio

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Harrow Health, Inc..


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items